What is the current DNA Genomic Testing market size?

The DNA Genomic Testing market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the DNA Genomic Testing market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the DNA Genomic Testing market?

Key drivers include advancements in technology and growing awareness of genetic diseases, fueling future outlook.

What challenges does the DNA Genomic Testing market face?

Challenges include high costs, regulatory hurdles, and concerns over data privacy and security.

Which regions are leading the DNA Genomic Testing market?

North America and Europe are currently leading the market, driven by strong healthcare infrastructure.

Who are the top companies in the DNA Genomic Testing market?

Top companies include Illumina, Thermo Fisher Scientific, and Qiagen, offering a range of genetic testing solutions.

What future opportunities exist in the DNA Genomic Testing market?

Future opportunities include increased adoption in emerging markets and expansion into new applications like precision medicine.

How is technology impacting the DNA Genomic Testing market?

Advances in sequencing technologies and artificial intelligence are improving test accuracy and efficiency, driving market growth.

What is the current regulatory landscape for DNA Genomic Testing?

The regulatory landscape is evolving, with increasing focus on ensuring test validity and protecting consumer data and privacy.

DNA Genomic Testing Growth Analysis & Future Outlook 2033

DNA Genomic Testing by Application (General Hospitals, Specialty Clinics), by Types (Predictive Presymptomatic Testing, Prenatal and Newborn Testing, Pharmacogenomic Testing, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 14.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 14.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

DNA Genomic Testing Market Size | CAGR 14.2 Forecast 2033

DNA Genomic Testing Growth Analysis & Future Outlook 2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 14.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 14.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

DNA Genomic Testing Market Overview

The DNA Genomic Testing market refers to the industry involved in the analysis of genomes to identify genetic variations associated with diseases and traits. As a rapidly evolving field, the DNA Genomic Testing market size is expected to experience significant growth, driven by advancements in technology and increasing demand for personalized medicine. The growth outlook for this market is promising, with a projected market forecast of $14.5 billion by 2026, growing at a CAGR of 12.3% during the forecast period of 2026-2033. This industry expansion is attributed to the rising adoption of genetic testing in clinical diagnosis and the growing importance of genomics in research and development. The scope of this market encompasses various segments, including genetic testing services, kits, and software, catering to diverse end-users such as hospitals, research institutions, and pharmaceutical companies.

Loading chart…

The largest region in the DNA Genomic Testing market is North America, driven by the presence of major market players and a well-established healthcare infrastructure. The fastest-growing region is expected to be Asia-Pacific, fueled by increasing investments in genomics research and the growing demand for genetic testing services. Key forces shaping the industry include technology shifts, such as the adoption of next-generation sequencing, regulations, such as the implementation of genetic data protection laws, and consumer behavior, driven by the increasing awareness of genetic health risks. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and developments to capitalize on emerging opportunities and navigate the complex landscape of the DNA Genomic Testing market.

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	34.71 billion
Growth rate	CAGR of 14.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; CSL; Danaher; Eurofins Scientific; F. Hoffmann-La Roche; Illumina; Myriad Genetics; Qiagen; Thermo Fisher Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The DNA Genomic Testing market is poised for significant growth, driven by various factors that are shaping its landscape. Understanding the market dynamics is crucial for stakeholders to navigate this complex and evolving space.

Growth Drivers2 items

Advancements in genomic sequencing technologies have significantly reduced the cost and increased the speed of DNA sequencing, making it more accessible and affordable for a wider range of applications, thus driving the DNA Genomic Testing market size.

Increasing demand for personalized medicine and targeted therapies is fueling the growth of the DNA Genomic Testing market, as genetic information becomes more critical for diagnosing and treating diseases, influencing the growth forecast.

Restraints2 items

The high cost of genomic data interpretation and the need for specialized expertise to analyze genomic data are significant restraints to the adoption of DNA Genomic Testing, impacting the DNA Genomic Testing market.

Concerns over genetic data privacy and the potential for genetic discrimination are also limiting factors, as they affect consumer trust and willingness to undergo DNA Genomic Testing, thereby influencing the market's growth forecast.

Opportunities2 items

The integration of artificial intelligence and machine learning in genomic analysis is creating new opportunities for the DNA Genomic Testing market, enabling faster and more accurate analysis of genomic data, and thus impacting the DNA Genomic Testing market size.

Expanding applications of DNA Genomic Testing in non-invasive prenatal testing, cancer screening, and pharmacogenomics are further opportunities for growth, driving innovation and adoption in the DNA Genomic Testing market.

Challenges2 items

The standardization of genomic testing protocols and the establishment of clear regulatory frameworks are significant challenges that the DNA Genomic Testing market must address to ensure consistency and reliability across different testing platforms, affecting the overall growth forecast.

The interpretation and validation of genomic data in the context of clinical decision-making remain a challenge, requiring ongoing research and collaboration between clinicians, researchers, and industry stakeholders to fully realize the potential of DNA Genomic Testing and understand its impact on the DNA Genomic Testing market size.

Market Segmentation

Loading chart…

The Application segment of the DNA Genomic Testing market refers to the various uses of genomic testing in different fields. This includes predictive testing, diagnostic testing, newborn screening, and carrier testing. Each of these applications contributes to the overall DNA Genomic Testing market size, with predictive testing being the largest contributor. The DNA Genomic Testing segmentation by application provides valuable insights into the market, with the predictive testing segment holding the largest share due to the increasing demand for early disease detection and prevention. Understanding this segmentation is crucial for market players to develop targeted strategies and capitalize on emerging trends.

The Types segment of the DNA Genomic Testing market comprises various subtypes, including genetic testing, chromosomal testing, and biochemical testing. Genetic testing is further divided into molecular testing and cytogenetic testing. Each subtype has its own unique characteristics and applications, contributing to the overall market size. The market taxonomy of DNA Genomic Testing types provides a comprehensive understanding of the market, enabling stakeholders to identify areas of growth and opportunities. By analyzing the types segment, market players can develop innovative products and services that cater to the evolving needs of the healthcare industry, ultimately driving the growth of the DNA Genomic Testing market.

DNA Genomic Testing Segmentation Breakdown8 items

Application

General Hospitals

Specialty Clinics

Types

Predictive Presymptomatic Testing

Prenatal and Newborn Testing

Pharmacogenomic Testing

Others

Regional Insights

Loading chart…

The DNA Genomic Testing market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of genomic testing, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include high ecosystem maturity, significant demographics with a large aging population, and a well-established infrastructure for genomic testing. In Europe, drivers include increasing adoption of precision medicine, favorable policies supporting genomic research, and a strong investment in healthcare technology. Asia Pacific's growth is driven by a large and growing middle class, increasing investment in genomic testing, and favorable policies supporting healthcare innovation.

Latin America's growth is driven by increasing adoption of genomic testing, improving infrastructure, and a growing middle class. The Middle East & Africa region is expected to experience growth driven by investments in healthcare infrastructure, increasing adoption of genomic testing, and a growing ecosystem of healthcare providers. The regional forecast indicates a significant opportunity for growth in the DNA Genomic Testing market, with each region presenting unique drivers and opportunities for market players.

Competitive Landscape

The DNA Genomic Testing market is moderately consolidated, driven by a mix of global players and local companies. The DNA Genomic Testing competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships, while local companies emphasize regional distribution networks and cost-effective solutions.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To address these challenges, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

Abbott: regional expansion

CSL: innovation pipeline

Danaher: vertical integration

Eurofins Scientific: premium pricing

F. Hoffmann-La Roche: OEM tie-ups

Illumina: local manufacturing

Key DNA Genomic Testing Companies9 items

Abbott

CSL

Danaher

Eurofins Scientific

F. Hoffmann-La Roche

Illumina

Myriad Genetics

Qiagen

Thermo Fisher Scientific

Market Ecosystem

The DNA Genomic Testing ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development and deployment of genomics-based tests, with technology providers supplying critical components and integrators assembling these into comprehensive testing solutions. Channels, including distributors and service providers, facilitate the delivery of these solutions to end users, such as healthcare providers and research institutions.

Technology providers — supplying genomics testing platforms

OEMs / manufacturers — producing testing equipment and reagents

System integrators / EPCs — integrating testing systems and software

Distributors / channel partners — delivering testing solutions to end users

Service providers / after-sales — offering maintenance and support services

End users / buyers — utilizing genomics testing solutions for research and diagnosis

Regulators/standards bodies — establishing guidelines and approvals for testing protocols

In the DNA Genomic Testing ecosystem, control points are primarily held by regulators and standards bodies, as they influence adoption through approvals and guidelines. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact the development of new testing solutions. Switching costs and interoperability requirements also play a crucial role, as end users may be invested in specific testing platforms, making it challenging to transition to alternative solutions. Furthermore, the ecosystem differs by region, with varying regulatory frameworks and market demands shaping the value chain analysis and development of genomics-based tests.

Recent Industry Insights

The DNA Genomic Testing industry has witnessed significant developments over the last 12-18 months, shaping the future of DNA Genomic Testing industry trends. Recent partnerships between leading genomics companies and research institutions have accelerated the discovery of new genetic markers and the development of more accurate testing methods. Notable mergers and acquisitions have also taken place, further consolidating the market and expanding the reach of key players. Furthermore, several product and technology launches have introduced more advanced and affordable testing solutions, making genomic testing more accessible to consumers and enterprises alike.

Additionally, regulatory changes have been implemented to ensure the safe and responsible use of genomic data, while a shift in consumer trends has led to increased demand for direct-to-consumer testing services. The industry has also seen significant funding rounds and expansions, with several companies securing substantial investments to drive innovation and growth. As the DNA Genomic Testing industry continues to evolve, these developments are expected to have a profound impact on its future trajectory, influencing DNA Genomic Testing industry trends and shaping the landscape for years to come.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the DNA Genomic Testing market. The market attractiveness is high, driven by increasing demand for personalized medicine and genetic research. The competitive intensity is moderate, with key players investing in research and development to stay ahead. The long-term DNA Genomic Testing market outlook is promising, with advancements in technology and decreasing costs expected to drive growth. Innovation is rapid, with new products and services emerging regularly. However, the demand-supply balance is a concern, with supply chain disruptions and regulatory challenges posing risks. Key risk factors include data privacy concerns and regulatory uncertainty. Overall, the market offers opportunities for growth, but players must navigate these challenges to succeed.

11 items

1. Executive Summary

2. DNA Genomic Testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global DNA Genomic Testing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global DNA Genomic Testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. General Hospitals

6.1.2. Specialty Clinics

6.2. Global DNA Genomic Testing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Predictive Presymptomatic Testing

6.2.2. Prenatal and Newborn Testing

6.2.3. Pharmacogenomic Testing

6.2.4. Others

6.3. Global DNA Genomic Testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global DNA Genomic Testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global DNA Genomic Testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global DNA Genomic Testing Market Competition by Key Manufacturers

8.1. Global DNA Genomic Testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global DNA Genomic Testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. CSL

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Danaher

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Eurofins Scientific

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. F. Hoffmann-La Roche

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Illumina

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Myriad Genetics

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Qiagen

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Thermo Fisher Scientific

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global DNA Genomic Testing Market

Figure 4: Global DNA Genomic Testing Market: Drivers

Figure 5: Global DNA Genomic Testing Market: Challenges

Figure 6: Global DNA Genomic Testing Market: Trends

Figure 7: Global DNA Genomic Testing Market: Opportunity

Figure 8: Global DNA Genomic Testing Market: Restraint

Figure 9: Global DNA Genomic Testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global DNA Genomic Testing Market Value (USD Million) By Region

Figure 15: Global DNA Genomic Testing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global DNA Genomic Testing Market Value (USD Million) By Region

Figure 23: Global DNA Genomic Testing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global DNA Genomic Testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global DNA Genomic Testing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global DNA Genomic Testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global DNA Genomic Testing Market Value (USD Million) By Region

Table 10: Global DNA Genomic Testing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global DNA Genomic Testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global DNA Genomic Testing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global DNA Genomic Testing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Basic Information And Sales Area

Table 31: Abbott. Products Portfolio

Table 32: CSL Basic Information And Sales Area

Table 33: CSL. Products Portfolio

Table 34: Danaher Basic Information And Sales Area

Table 35: Danaher. Products Portfolio

Table 36: Eurofins Scientific Basic Information And Sales Area

Table 37: Eurofins Scientific. Products Portfolio

Table 38: F. Hoffmann-La Roche Basic Information And Sales Area

Table 39: F. Hoffmann-La Roche. Products Portfolio

Table 40: Illumina Basic Information And Sales Area

Table 41: Illumina. Products Portfolio

Table 42: Myriad Genetics Basic Information And Sales Area

Table 43: Myriad Genetics. Products Portfolio

Table 44: Qiagen Basic Information And Sales Area

Table 45: Qiagen. Products Portfolio

Table 46: Thermo Fisher Scientific Basic Information And Sales Area

Table 47: Thermo Fisher Scientific. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Application

Table 49: Global Market Share (%) By Application (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Types

Table 51: Global Market Share (%) By Types (2032)

Table 52: Global DNA Genomic Testing Market Value (USD Million) By Region

Table 53: Global DNA Genomic Testing Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Application

Table 56: North America Market Value (USD Million) (2025-2032) By Types

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Types

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Types

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

DNA Genomic Testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	34.71 billion
Growth rate	CAGR of 14.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; CSL; Danaher; Eurofins Scientific; F. Hoffmann-La Roche; Illumina; Myriad Genetics; Qiagen; Thermo Fisher Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options